This invention is directed to pharmaceutical compositions comprising 3 adrenergic agonists including -2-hydroxyethylamino)ethoxy)phenyl)acetic acid and growth hormone or growth hormone secretagogues, prodrugs thereof or pharmaceutically acceptable salts of said compounds or said prodrugs. Each one of the inks contains at least one water-soluble dye as a principal colorant, a solvent, and one or more anti-drying agents. The dynamic support element is positioned in the sole such that it expands at least partially beneath the area corresponding to the front part of the foot.